سعر ريكوكسبرايت 90مجم 30 قرص 2024

Etoricoxib 90 mg oral tablets (30), a selective COX-2 inhibitor NSAID for osteoarthritis, rheumatoid arthritis, ankylosing spondylitis, acute gout and short-term dental post-operative pain.

• Symptomatic relief of osteoarthritis, rheumatoid arthritis, ankylosing spondylitis, and pain and signs of inflammation associated with acute gouty arthritis.Population: Adults and adolescents 16 years and olderelectronic medicines compendium (eMC)
• Short-term treatment of moderate pain associated with dental surgery.Population: Adults and adolescents 16 years and olderelectronic medicines compendium (eMC)

• Very common: abdominal pain. Common: alveolar osteitis, oedema/fluid retention, dizziness, headache, palpitations, arrhythmia, hypertension, bronchospasm, GI disorders (constipation, flatulence, gastritis, heartburn, diarrhoea, dyspepsia, nausea), ALT/AST increased, ecchymosis, asthenia/fatigue, flu-like illness.International label, same formulation · electronic medicines compendium (eMC)

• Hypersensitivity to etoricoxib or excipients.International label, same formulation · electronic medicines compendium (eMC)
• Active peptic ulceration or active gastrointestinal bleeding.International label, same formulation · electronic medicines compendium (eMC)
• History of bronchospasm, acute rhinitis, nasal polyps, angioneurotic oedema, urticaria or allergic reactions after aspirin or NSAIDs (including COX-2 inhibitors).International label, same formulation · electronic medicines compendium (eMC)

• Upper GI complications (perforations, ulcers, bleeding), some fatal, can occur; higher risk in the elderly, with concomitant aspirin/NSAIDs or prior GI disease.International label, same formulation · electronic medicines compendium (eMC)
• Selective COX-2 inhibitors may carry an increased risk of thrombotic events (especially MI and stroke); risk may rise with dose and duration.International label, same formulation · electronic medicines compendium (eMC)
• Renal prostaglandin inhibition may reduce renal perfusion; monitor renal function in at-risk patients.International label, same formulation · electronic medicines compendium (eMC)

• Warfarin (oral anticoagulants)Etoricoxib 120 mg daily increased prothrombin time INR by about 13%; monitor INR when starting or changing etoricoxib.electronic medicines compendium (eMC)
• Diuretics, ACE inhibitors, angiotensin II antagonistsNSAIDs may reduce the antihypertensive effect and, in compromised renal function, increase the risk of renal impairment.electronic medicines compendium (eMC)
• Acetylsalicylic acid (aspirin)Low-dose aspirin can be co-administered but increases GI ulceration risk; not a substitute for aspirin cardiovascular prophylaxis.electronic medicines compendium (eMC)

• Contraindicated in pregnancy; in the third trimester NSAIDs may cause premature closure of the ductus arteriosus and uterine inertia. Discontinue if pregnancy occurs.International label, same formulation · electronic medicines compendium (eMC)
• Unknown whether excreted in human milk (excreted in rat milk); women using etoricoxib must not breastfeed.International label, same formulation · electronic medicines compendium (eMC)

• Etoricoxib: Selective inhibition of COX-2, reducing prostaglandin formation involved in pain and inflammation.